Belships ASA: Key information relating to the cash dividend to be paid by Belships ASA
Oslo, 9 November 2023
The distribution will be made from previously paid in capital.
Dividend amount: NOK 0.45 per share
Declared currency: NOK
Last day including right: 10 November 2023
Ex-date: 13 November 2023
Record date: 14 November 2023
Payment date: 22 November 2023
Date of board resolution: 8 November 2023
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
75% Load Factor, 42% increase in passenger numbers and demand picking up7.12.2023 17:50:00 CET | Press release
75% Load Factor, 42% increase in passenger numbers and demand picking up PLAY airlines carried 107,236 passengers in November, which is a 42% increase from November 2022 when PLAY carried 75,396 passengers. The load factor in November 2023 was 74.5%, down from 79% last year. This decline in load factor is a direct result of the seismic activity in the Reykjanes Peninsula and resulting global news coverage of a possible volcanic eruption that could disrupt aviation. This situation impacted last-minute bookings in the month. PLAY had an on-time performance of 88.9% in November 2023. Despite the decline in load factor in November we continued to see year-on-year growth in our unit revenue (RASK), even with a 54% growth in available seat kilometers (ASK).Average ancillary revenue continues to rise for PLAY, being 30% higher in November 2023 compared to November 2022, and the trend is looking strong for the coming months. Of all passengers flying with PLAY in November 2023, 26.2% were depar
Innofactor Plc: Share Repurchase 7.12.20237.12.2023 17:30:00 CET | Press release
Innofactor Plc Announcement 7.12.2023Innofactor Plc: Share Repurchase 7.12.2023In the Helsinki Stock ExchangeTrade date 7.12.2023Bourse trade BuyShare IFA1VAmount 4,500SharesAverage price/ share 1.1494EURTotal cost 5,172.30EURInnofactor Plc now holds a total of 575 629 sharesincluding the shares repurchased on 7.12.2023On behalf of Innofactor PlcNordea Bank OyjJanne Sarvikivi Sami HuttunenAdditional information:Sami Ensio, CEOInnofactor PlcTel. +358 50 584 2029sami.ensio@innofactor.comwww.innofactor.com Attachment Innofactor_7.12_trades
Coloplast A/S - Skift af revisor7.12.2023 17:29:40 CET | pressemeddelelse
I dag, den 7. december 2023, har Coloplast A/S afholdt ordinær generalforsamling, hvor EY Godkendt Revisionspartnerselskab blev valgt som Coloplast A/S’ revisor i overensstemmelse med forslaget fra bestyrelsen. For yderligere information, kontakt venligst Investorer og analytikere Anders Lonning-Skovgaard Koncerndirektør, CFO Tlf. 4911 1111 Aleksandra Dimovska Senior Director, Investor Relations Tlf. 4911 1800 / 4911 2458 E-mail: dkadim@coloplast.com Kristine Husted Munk Senior Manager, Investor Relations Tlf. 4911 1800 / 4911 3266 E-mail: dkkhu@coloplast.com Presse og medier Peter Mønster Sr. Media Relations Manager Tlf. 4911 2623 Email: dkpete@coloplast.com Adresse Coloplast A/S Holtedam 1 3050 Humlebæk Danmark CVR Nr. 69749917 Hjemmeside www.coloplast.com Denne selskabsmeddelelse foreligger på dansk og engelsk. I tvivlstilfælde er den engelske version gældende. Coloplast blev grundlagt på passion, ambition og engagement. Vi opstod på grundlag af en sygeplejerskes ønske om at hjælpe
Coloplast A/S - Change of auditor7.12.2023 17:29:40 CET | Press release
Today, 7 December 2023, Coloplast A/S held its Annual General Meeting, at which EY Godkendt Revisionspartnerselskab was elected as Coloplast A/S’ auditors in line with the proposal from the Board of Directors. For further information, please contact Investors and analysts Anders Lonning-Skovgaard Executive Vice President, CFO Tel. +45 4911 1111 Aleksandra Dimovska Senior Director, Investor Relations Tel. +45 4911 1800 / +45 4911 2458 Email: dkadim@coloplast.com Kristine Husted Munk Senior Manager, Investor Relations Tel. +45 4911 1800 / +45 4911 3266 Email: dkkhu@coloplast.com Press and media Peter Mønster Sr. Media Relations Manager Tel. +45 4911 2623 Email: dkpete@coloplast.com Address Coloplast A/S Holtedam 1 DK-3050 Humlebaek Denmark Company reg. (CVR) no. 69749917 Website www.coloplast.com This announcement is available in a Danish and an English-language version. In the event of discrepancies, the English version shall prevail. Coloplast was founded on passion, ambition, and comm
Coloplast A/S - Articles of Association7.12.2023 17:26:55 CET | Press release
Articles of association for Coloplast A/S as adopted at the Annual General Meeting of Coloplast A/S held today, 7 December 2023 are enclosed. For further information, please contact Investors and analysts Anders Lonning-Skovgaard Executive Vice President, CFO Tel. +45 4911 1111 Aleksandra Dimovska Senior Director, Investor Relations Tel. +45 4911 1800 / +45 4911 2458 Email: dkadim@coloplast.com Kristine Husted Munk Senior Manager, Investor Relations Tel. +45 4911 1800 / +45 4911 3266 Email: dkkhu@coloplast.com Press and media Peter Mønster Sr. Media Relations Manager Tel. +45 4911 2623 Email: dkpete@coloplast.com Address Coloplast A/S Holtedam 1 DK-3050 Humlebaek Denmark Company reg. (CVR) no. 69749917 Website www.coloplast.com This announcement is available in a Danish and an English-language version. In the event of discrepancies, the English version shall prevail. Coloplast was founded on passion, ambition, and commitment. We were born from a nurse’s wish to help her sister and the